Developer docs
API playgroundTry for free, no card

Search company profiles

LifeLens

Full company profile

uuid003fa13

Namestring
LifeLens
Websiteurl
thelifelens.com
Company typeenum
Private
Founded yearstring
-
Short descriptiontext

LifeLens is a Nashville-based private company whose stated mission is to develop a low-cost, smartphone-based diagnostic solution for use in the developing world. No products, customers, pricing, or operational details are disclosed in available sources.

Ownership categoryenum
akta.pro rankint
HeadquartersNashville, United States
HQ citystring
Nashville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
smartphone diagnostics, mobile health diagnostics, low-cost medical diagnostics, point-of-care diagnostics, developing world health
Industry3 codes
1Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices)
CodeHLACAPAKPrimaryYes
2Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)
CodeHLAHACALPrimaryNo
3Home Diagnostic & Self-Test OTC Kits
CodeHLAIADAOPrimaryNo
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Mobile Health Diagnostics
Social media profiles2 records
Cost components1 value
Technology or R&D
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

LifeLens is dedicated to creating a low-cost smartphone-based solution for diagnostics in the developing world. The company appears focused on leveraging smartphone hardware to enable accessible diagnostic testing in low-resource settings.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Smartphone-Based Diagnostics Solution
CategoryMobile Health Diagnostics
No data
Peers10 records
TypeBroad incumbent
Description

Cue Health offers a connected, consumer-facing at-home molecular diagnostic platform. Overlaps with LifeLens in the connected/consumer diagnostic category but operates at much larger scale in developed markets.

TypeDirect peer
Description

Hemex Health builds low-cost, portable diagnostic devices (e.g., for malaria and sickle cell) intended for use in resource-limited settings. Closely aligned with LifeLens's low-cost diagnostics-for-developing-world thesis.

TypeDirect peer
Description

Jana Care develops smartphone-based point-of-care diagnostic tests for chronic disease (e.g., kidney disease, diabetes) targeted at emerging markets. Highly comparable to LifeLens given the shared smartphone-based diagnostic model and LMIC focus.

TypeDirect peer
Description

Fio developed the Deki smartphone-connected rapid diagnostic reader used for disease screening in low-resource settings, directly mirroring LifeLens's smartphone-based developing-world diagnostic model.

TypeDirect peer
Description

Biomeme makes a smartphone-controlled portable PCR system used for infectious disease detection in field settings, including LMIC deployments. Strong overlap with LifeLens's smartphone + diagnostics + developing-world model.

TypeDirect peer
Description

QuantuMDx is developing a portable, battery-powered molecular diagnostics device for infectious disease testing at the point of need, including in low-resource settings. Directly comparable in product and mission.

TypeEmerging player
Description

GlobalDiagnostiX focuses on low-cost, ruggedized imaging/diagnostic hardware for developing-world healthcare. Closely comparable mission (low-cost diagnostics for the developing world), with narrower product scope.

TypeDirect peer
Description

Molbio (which absorbed Truelab) produces portable, battery-operated molecular diagnostic platforms deployed widely in emerging markets for tuberculosis, COVID-19, and other diseases. Competes directly in the low-cost POC diagnostics category.

TypeDirect peer
Description

SystemOne connects diagnostic devices (e.g., GeneXpert) in low- and middle-income countries to a cloud platform for real-time disease surveillance. Comparable as an enabling layer for diagnostics in emerging markets.

TypeEmerging player
Description

DxNow has developed smartphone-based diagnostic platforms (e.g., for fertility, infectious disease) at low cost. Comparable as a smartphone-native diagnostic peer in the connected POC space.

Market position
Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

LifeLens

Mobile Health Diagnosticsthelifelens.com

LifeLens is a Nashville-based private company whose stated mission is to develop a low-cost, smartphone-based diagnostic solution for use in the developing world. No products, customers, pricing, or operational details are disclosed in available sources.

LifeLens firmographics

Firmographics
Name
LifeLens
Website
https://thelifelens.com
Company type
Private
Short description
LifeLens is a Nashville-based private company whose stated mission is to develop a low-cost, smartphone-based diagnostic solution for use in the developing world. No products, customers, pricing, or operational details are disclosed in available sources.
Ownership category
akta.pro rank

LifeLens industry classification

Industry
Product category
Mobile Health Diagnostics
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Surgical & Medical Instruments & Apparatus (3841), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro primary industry
Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK)
akta.pro secondary industries
Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL), Home Diagnostic & Self-Test OTC Kits (HLAIADAO)

Keywords

  • Smartphone diagnostics
  • Mobile health diagnostics
  • Low-cost medical diagnostics
  • Point-of-care diagnostics
  • Developing world health

Where LifeLens is headquartered

Location

Headquarters

HQ city
Nashville
HQ country
United States
HQ region
North America

Markets served

LifeLens business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D

LifeLens product offering

Product offering

Core offering

LifeLens is dedicated to creating a low-cost smartphone-based solution for diagnostics in the developing world. The company appears focused on leveraging smartphone hardware to enable accessible diagnostic testing in low-resource settings.

Differentiator

Problem solved

Functional benefit

Products and services

  • Smartphone-Based Diagnostics Solution

Companies that use LifeLens

Customer profile

Ideal customer profiles1 record

LifeLens technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

LifeLens competitors and assessment

Company assessment

Broad incumbents

  • Cue Health: Cue Health offers a connected, consumer-facing at-home molecular diagnostic platform. Overlaps with LifeLens in the connected/consumer diagnostic category but operates at much larger scale in developed markets.

Direct peers

  • Hemex Health: Hemex Health builds low-cost, portable diagnostic devices (e.g., for malaria and sickle cell) intended for use in resource-limited settings. Closely aligned with LifeLens's low-cost diagnostics-for-developing-world thesis.
  • Jana Care: Jana Care develops smartphone-based point-of-care diagnostic tests for chronic disease (e.g., kidney disease, diabetes) targeted at emerging markets. Highly comparable to LifeLens given the shared smartphone-based diagnostic model and LMIC focus.
  • Fio Corporation: Fio developed the Deki smartphone-connected rapid diagnostic reader used for disease screening in low-resource settings, directly mirroring LifeLens's smartphone-based developing-world diagnostic model.
  • Biomeme: Biomeme makes a smartphone-controlled portable PCR system used for infectious disease detection in field settings, including LMIC deployments. Strong overlap with LifeLens's smartphone + diagnostics + developing-world model.
  • QuantuMDx: QuantuMDx is developing a portable, battery-powered molecular diagnostics device for infectious disease testing at the point of need, including in low-resource settings. Directly comparable in product and mission.
  • Molbio Diagnostics: Molbio (which absorbed Truelab) produces portable, battery-operated molecular diagnostic platforms deployed widely in emerging markets for tuberculosis, COVID-19, and other diseases. Competes directly in the low-cost POC diagnostics category.
  • SystemOne: SystemOne connects diagnostic devices (e.g., GeneXpert) in low- and middle-income countries to a cloud platform for real-time disease surveillance. Comparable as an enabling layer for diagnostics in emerging markets.

Emerging players

  • GlobalDiagnostiX: GlobalDiagnostiX focuses on low-cost, ruggedized imaging/diagnostic hardware for developing-world healthcare. Closely comparable mission (low-cost diagnostics for the developing world), with narrower product scope.
  • DxNow: DxNow has developed smartphone-based diagnostic platforms (e.g., for fertility, infectious disease) at low cost. Comparable as a smartphone-native diagnostic peer in the connected POC space.

Market position

Customer concentration

LifeLens social profiles

Digital presence

LifeLens financial estimates

Financial estimate

Revenue estimate

Valuation estimate

LifeLens leadership team

Management profile

Number of profiles

LifeLens funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

LifeLens M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LifeLens

What does LifeLens do?

LifeLens is dedicated to creating a low-cost smartphone-based solution for diagnostics in the developing world. The company appears focused on leveraging smartphone hardware to enable accessible diagnostic testing in low-resource settings.

When was LifeLens founded?

LifeLens was founded in -1.

Where is LifeLens based?

LifeLens is headquartered in Nashville, United States, in the North America region.

Who are LifeLens's main competitors?

Cue Health is listed as a broad incumbent. Direct peers are Hemex Health, Jana Care, Fio Corporation, Biomeme, QuantuMDx, Molbio Diagnostics and SystemOne. Emerging players are GlobalDiagnostiX and DxNow.

Does LifeLens have an API?

No public API is recorded for LifeLens.

What industry is LifeLens in?

LifeLens's product category is Mobile Health Diagnostics. Its primary akta.pro industry code is HLACAPAK, Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices), with a secondary code of HLAHACAL, Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers). Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales